VivoSeq
Other

Antiviral Drug

0

Pipeline Programs↗

1

Active Trials↗

2

Companies Involved↗

Antiviral Drug is an early-stage landscape with 0 programs across 2 companies. The most active players are Just-Evotec Biologics, Eli Lilly.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

J

Just-Evotec Biologics

1 program

Phase 1Eli Lilly logo

Eli Lilly

1 program

Phase 1

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

7

clinical trials

Unknown status4 · 57%
Completed2 · 29%
Recruiting1 · 14%

Clinical Trials

Trial Activity

7 trials

Phase 1, Randomized, Double-blind, Placebo-controlled, Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of JST-018 in Healthy Adults
Recruiting·JJust-Evotec Biologics·Phase 1·NCT07595458·48 enrolled
Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix
Completed·—·Phase 3·NCT02346227·327 enrolled
Antiviral Drugs on the Treatment of SARS-CoV-2
Completed·—·N/A·NCT04727775·150 enrolled
Effect of Direct-acting Antiviral Drugs on Erectile Function
Unknown status·—·Phase 3·NCT03444272·105 enrolled
Effect of Direct AntiViral Drugs of Chronic HCV on eGFR in Assuit Universiry Hospital
Unknown status·—·N/A·NCT03965286·80 enrolled
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers of the Novel Self-Administered Intranasal CG- SpikeDown Antiviral Drug
Unknown status·CCaregen Co. Ltd.·Phase 1·NCT05234320·16 enrolled
Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.
Unknown status·UUniversity of Modena and Reggio Emilia·Phase 4·NCT02950870·75 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)